The Role of Real-World Evidence in UK Reimbursement: Case Study of Lenalidomide in Myelodysplastic Syndrome Deletion 5q.

Name: The Role of Real-World Evidence in UK Reimbursement: Case Study of Lenalidomide in Myelodysplastic Syndrome Deletion 5q.
Author: Lee, Dawn

The Role of Real-World Evidence in UK Reimbursement: Case Study of Lenalidomide in Myelodysplastic Syndrome Deletion 5q. — المؤلف: Lee, Dawn — PharmacoEconomics - open Sep 2019

المؤلف: Lee, Dawn
النشر: PharmacoEconomics - open Sep 2019
الوصف: 351-358 p.